# Lecture 5: Control of Breathing
## Unit 1.8: Respiratory System
---
## Learning Objectives
By the end of this lecture, students will be able to:
1. Identify the central respiratory control centers and their functions
2. Describe the role of chemoreceptors in regulating ventilation
3. Explain the ventilatory responses to CO₂, O₂, and pH
4. Describe the contribution of mechanoreceptors to breathing control
5. Explain integrated responses to exercise and altitude
6. Apply respiratory control concepts to clinical scenarios
---
## Lecture Content
### I. Central Respiratory Control
Breathing occurs automatically and rhythmically throughout life, driven by neural centers in the brainstem that generate the respiratory pattern and modulate it in response to metabolic demands. Understanding these control mechanisms explains both normal respiratory physiology and the pathological breathing patterns encountered in clinical practice.
The medullary respiratory center constitutes the fundamental rhythm generator for breathing. Located in the medulla oblongata, this center contains two functionally distinct groups of neurons. The dorsal respiratory group, situated in the nucleus tractus solitarius, receives afferent input from peripheral sensors and primarily controls inspiration. These neurons fire with increasing intensity during inspiration, driving the diaphragm and external intercostals to contract. The ventral respiratory group, located in the nucleus ambiguus and retrofacial nucleus, contains both inspiratory and expiratory neurons. While some ventral respiratory neurons contribute to inspiration, this group primarily activates during forced expiration, driving the internal intercostals and abdominal muscles.
The pontine respiratory centers modulate the medullary rhythm generators. The pneumotaxic center in the upper pons limits inspiration by inhibiting the dorsal respiratory group, effectively controlling the duration and depth of each breath. Lesions of the pneumotaxic center produce prolonged inspiratory efforts. The apneustic center in the lower pons has the opposite effect, promoting inspiration by stimulating the dorsal respiratory group. In isolation, the apneustic center produces apneustic breathing characterized by prolonged inspiratory gasps.
Within the ventral respiratory group lies the pre-Bötzinger complex, identified as the primary pacemaker for respiratory rhythm. These neurons possess intrinsic rhythmic activity and initiate the inspiratory phase. The Bötzinger complex, located more rostrally, contains expiratory neurons that inhibit inspiratory activity, helping terminate inspiration and initiate expiration.
The normal inspiratory pattern follows a characteristic ramp signal. Rather than abruptly activating, inspiratory neuron firing gradually increases over approximately two seconds, creating smooth inspiratory muscle contraction and gradual chest expansion. At a threshold determined by the pneumotaxic center and other inputs, an off-switch mechanism abruptly terminates inspiration. Expiration then proceeds passively as inspiratory neurons are inhibited, allowing elastic recoil to drive air out of the lungs.
Panel A: Sagittal brainstem section showing pneumotaxic center in upper pons (blue) and apneustic center in lower pons (green). Panel B: Medullary respiratory center with dorsal respiratory group (yellow) and ventral respiratory group (orange) containing pre-Botzinger and Botzinger complexes. Panel C: Functional relationship arrows showing pneumotaxic center inhibiting inspiration while apneustic center promotes it. Panel D: Time-based graph of inspiratory neuron ramp signal with gradual increase followed by abrupt termination.
---
### II. Chemoreceptors
Chemoreceptors monitor blood gas composition and pH, providing feedback that adjusts ventilation to maintain homeostasis. Two distinct populations of chemoreceptors serve complementary roles in this regulatory system.
Central chemoreceptors lie on the ventral surface of the medulla, bathed by cerebrospinal fluid. These receptors respond primarily to hydrogen ion concentration in the cerebrospinal fluid, which in turn reflects arterial carbon dioxide tension. Carbon dioxide crosses the blood-brain barrier freely, while hydrogen ions and bicarbonate cross slowly. When arterial carbon dioxide rises, carbon dioxide diffuses rapidly into the cerebrospinal fluid, combines with water to form carbonic acid, and dissociates to release hydrogen ions. This acidification of the cerebrospinal fluid stimulates the central chemoreceptors, which signal the respiratory centers to increase ventilation.
The central chemoreceptors contribute approximately 80 percent of the ventilatory response to elevated carbon dioxide, making them the dominant sensors for carbon dioxide homeostasis. Cerebrospinal fluid has less buffering capacity than blood, so a given rise in carbon dioxide produces a larger pH change in the cerebrospinal fluid than in arterial blood, enhancing sensitivity. Importantly, central chemoreceptors cannot detect oxygen directly; they respond only to hydrogen ions derived from carbon dioxide.
Peripheral chemoreceptors provide the remaining chemosensory input and possess broader sensory capabilities. The carotid bodies, located at the bifurcation of the common carotid arteries, send signals via the glossopharyngeal nerve. The aortic bodies, located in the aortic arch, send signals via the vagus nerve. Both receptor groups respond to decreased arterial oxygen tension, increased carbon dioxide tension, and decreased pH.
The carotid bodies receive extraordinarily high blood flow relative to their small mass, ensuring that the blood they sample accurately reflects arterial composition rather than local tissue metabolism. Importantly, these receptors sense oxygen partial pressure rather than oxygen content, meaning they respond to hypoxemia but not to anemia or carbon monoxide poisoning where partial pressure may be normal despite reduced oxygen delivery.
The mechanism of oxygen sensing involves potassium channels in glomus cells of the carotid body. Hypoxia inhibits these channels, causing membrane depolarization, calcium influx, and neurotransmitter release that stimulates afferent nerve fibers. The oxygen response remains minimal until arterial oxygen partial pressure falls below approximately 60 mmHg, at which point ventilatory drive increases substantially.
Panel A: Medulla cross-section showing central chemoreceptors on ventral surface adjacent to CSF with CO2 crossing blood-brain barrier and converting to H+ ions. Panel B: Carotid body location at carotid bifurcation with glossopharyngeal nerve and aortic bodies in aortic arch with vagus nerve. Panel C: Comparison table showing central chemoreceptors respond to CSF H+ providing 80% of CO2 response versus peripheral chemoreceptors detecting PO2, PCO2, and pH providing sole O2 sensing. Panel D: Neural pathways converging from both receptor types to medullary respiratory center.
---
### III. Ventilatory Response to Carbon Dioxide
Carbon dioxide serves as the primary chemical stimulus regulating ventilation in normal physiology. The ventilatory response to carbon dioxide follows a predictable pattern that can be modified by various physiological and pathological states.
The carbon dioxide response curve demonstrates a nearly linear relationship between arterial carbon dioxide tension and minute ventilation. For each millimeter of mercury increase in arterial carbon dioxide tension, ventilation increases by approximately 2 to 3 liters per minute. This sensitive response maintains arterial carbon dioxide tension tightly controlled at approximately 40 mmHg under normal conditions.
The apneic threshold represents the lower limit of the carbon dioxide response. When arterial carbon dioxide falls below approximately 35 to 40 mmHg, ventilatory drive diminishes to the point of apnea. This threshold explains why aggressive hyperventilation, whether voluntary or mechanical, can lead to central apnea.
Several factors shift the carbon dioxide response curve. Hypoxemia and metabolic acidosis both shift the curve leftward, increasing sensitivity so that any given carbon dioxide level produces greater ventilation. This enhanced responsiveness appropriately increases ventilation when additional metabolic stress demands it. Rightward shifts, indicating decreased sensitivity, occur during sleep, with sedative drugs and opioids, and in chronic hypercapnia. Opioids in particular potently suppress the carbon dioxide response, contributing to respiratory depression in overdose.
Chronic hypercapnia represents a particularly important clinical scenario. In patients with chronic obstructive pulmonary disease who retain carbon dioxide over weeks to months, renal compensation increases bicarbonate retention and normalizes cerebrospinal fluid pH despite elevated carbon dioxide tension. With normalized cerebrospinal fluid pH, the central chemoreceptor drive diminishes, resetting the carbon dioxide response to higher baseline levels. These patients may become dependent on hypoxic drive from peripheral chemoreceptors as their primary ventilatory stimulus, creating a hazard when supplemental oxygen is administered.
Panel A: CO2 response curve graph with arterial PCO2 (30-60 mmHg) on x-axis and minute ventilation (0-40 L/min) on y-axis showing steep normal response slope of 2-3 L/min per mmHg. Panel B: Leftward-shifted curves indicating enhanced sensitivity from hypoxemia and metabolic acidosis versus rightward-shifted curves from sleep, opioids, and chronic hypercapnia. Panel C: Apneic threshold marked at 35-40 mmHg where curve intersects x-axis. Panel D: Chronic hypercapnia adaptation showing renal bicarbonate retention normalizing CSF pH with reduced central chemoreceptor drive and reliance on hypoxic drive.
---
### IV. Ventilatory Response to Oxygen
The ventilatory response to hypoxemia depends entirely on peripheral chemoreceptors, as central chemoreceptors cannot detect oxygen. This response has important characteristics that distinguish it from the carbon dioxide response.
The oxygen response curve demonstrates a hyperbolic rather than linear relationship. Ventilation remains relatively unchanged as arterial oxygen partial pressure falls from normal levels of 100 mmHg down to approximately 60 mmHg, corresponding to the flat upper portion of the oxygen-hemoglobin dissociation curve where saturation remains high. Below 60 mmHg, ventilation increases sharply as peripheral chemoreceptors signal impending hypoxemic crisis. This threshold corresponds to the steep portion of the oxygen-hemoglobin dissociation curve where saturation falls rapidly.
The mechanism of oxygen sensing in carotid body glomus cells involves oxygen-sensitive potassium channels. Under normoxic conditions, these channels remain open, maintaining negative membrane potential. Hypoxia inhibits the channels, reducing potassium efflux and causing depolarization. Voltage-gated calcium channels then open, allowing calcium influx that triggers neurotransmitter release and afferent nerve stimulation.
Carbon dioxide and oxygen interact synergistically in stimulating ventilation. Hypoxemia enhances the ventilatory response to carbon dioxide, shifting the carbon dioxide response curve leftward. Similarly, hypercapnia enhances the hypoxic response. These interactions ensure that combined hypoxemia and hypercapnia produce greater ventilatory stimulation than either alone.
The clinical significance of oxygen sensing extends to several scenarios. At high altitude, the hypoxic ventilatory response drives the initial hyperventilation that partially compensates for reduced inspired oxygen tension. In patients with chronic obstructive pulmonary disease who have developed chronic hypercapnia and blunted carbon dioxide response, the hypoxic drive may become the primary ventilatory stimulus. Administering high-flow supplemental oxygen to such patients can suppress this drive, potentially worsening hypoventilation and carbon dioxide retention. This effect underlies the practice of targeting oxygen saturation to 88 to 92 percent in such patients.
Panel A: Oxygen response curve with arterial PO2 (0-100 mmHg) on x-axis showing hyperbolic curve flat from 100 to 60 mmHg then rising steeply with threshold at 60 mmHg labeled. Panel B: Multiple curves demonstrating synergistic hypercapnia effect with higher PCO2 values shifting curves upward and leftward enhancing hypoxic response. Panel C: Glomus cell mechanism showing hypoxia inhibiting potassium channels causing depolarization, calcium entry, and neurotransmitter release. Panel D: Clinical annotations showing relevance to altitude acclimatization and COPD oxygen therapy targeting SpO2 88-92%.
---
### V. Ventilatory Response to pH
Changes in blood pH independent of carbon dioxide also affect ventilation, primarily through peripheral chemoreceptors. This response serves as respiratory compensation for metabolic acid-base disturbances.
Metabolic acidosis, characterized by reduced blood pH from accumulation of fixed acids or loss of bicarbonate, stimulates peripheral chemoreceptors to increase ventilation. The resulting hyperventilation reduces arterial carbon dioxide, raising pH toward normal. Kussmaul breathing, the deep and rapid respiratory pattern seen in diabetic ketoacidosis, represents an extreme example of this compensatory hyperventilation. The primary mechanism involves peripheral chemoreceptor stimulation by low pH, although some contribution from central chemoreceptors may occur as hydrogen ions slowly cross the blood-brain barrier.
The expected degree of respiratory compensation for metabolic acidosis can be calculated using Winter's formula: expected arterial carbon dioxide equals 1.5 times the serum bicarbonate plus 8, with a range of plus or minus 2. If measured carbon dioxide falls below this expected value, a concurrent respiratory alkalosis exists. If measured carbon dioxide exceeds the expected value, respiratory compensation is inadequate, suggesting a concurrent respiratory acidosis.
Metabolic alkalosis, characterized by elevated blood pH, suppresses peripheral chemoreceptor activity and reduces ventilatory drive. Carbon dioxide retention raises arterial carbon dioxide tension, moving pH back toward normal. However, respiratory compensation for metabolic alkalosis is limited because rising carbon dioxide and falling oxygen from hypoventilation eventually stimulate ventilation. The expected compensation approximates an increase in arterial carbon dioxide of 0.7 mmHg for each milliequivalent per liter increase in serum bicarbonate.
The limits of respiratory compensation reflect the balance between pH regulation and oxygen requirements. Complete correction of pH through respiratory compensation alone would require either apnea (impossible) in metabolic alkalosis or such profound hyperventilation that respiratory muscle fatigue develops in metabolic acidosis.
Panel A: Metabolic acidosis showing H+ ions stimulating peripheral chemoreceptors leading to hyperventilation reducing PCO2 with Kussmaul breathing as deep rapid respirations. Panel B: Winter's formula displayed with example calculation for expected respiratory compensation. Panel C: Metabolic alkalosis showing reduced chemoreceptor stimulation causing hypoventilation and PCO2 retention limited by hypoxemia. Panel D: Graph of arterial pH versus minute ventilation showing increased ventilation in acidosis and decreased ventilation in alkalosis with oxygen requirement limitations.
---
### VI. Mechanoreceptors and Reflexes
In addition to chemical signals, mechanical information from the lungs and respiratory system influences breathing pattern. Various mechanoreceptors detect lung inflation, irritants, and interstitial pressure changes, modulating ventilation through reflex pathways.
Slowly adapting pulmonary stretch receptors lie within airway smooth muscle and respond to lung inflation. As the lung expands during inspiration, these receptors fire with increasing frequency, sending signals via the vagus nerve to the brainstem. When firing exceeds a threshold, inspiratory activity is inhibited, terminating inspiration. This Hering-Breuer inflation reflex prevents overinflation of the lungs. While important in regulating tidal volume in infants, the reflex plays a more modest role in adults, becoming significant only at large tidal volumes.
Rapidly adapting receptors, also called irritant receptors, reside in the airway epithelium and respond to irritants, rapid changes in lung volume, and mechanical deformation. These receptors trigger defensive reflexes including coughing, bronchoconstriction, and mucus secretion. Stimulation by inhaled particles, chemicals, or inflammation produces the familiar sensation of airway irritation and the urge to cough.
Juxtacapillary receptors, commonly called J receptors, lie in the alveolar walls near pulmonary capillaries. These receptors respond to interstitial congestion, edema, and chemical mediators. Stimulation produces rapid, shallow breathing along with sensations of dyspnea. Pulmonary edema and interstitial inflammation activate J receptors, contributing to the breathing pattern and distress seen in conditions such as heart failure and acute respiratory distress syndrome.
Respiratory muscle receptors, including muscle spindles in intercostal muscles and tendon organs in the diaphragm, provide proprioceptive feedback about muscle length and tension. This information helps compensate for added respiratory loads, maintaining tidal volume when resistance increases. Chest wall joint receptors contribute positional information.
Upper airway receptors in the nose and pharynx trigger protective reflexes. Nasal irritant receptors initiate sneezing. Pharyngeal receptors respond to negative pressure during inspiration, helping maintain airway patency. The diving reflex, triggered by cold water on the face, produces apnea and bradycardia through trigeminal nerve afferents.
Panel A: Airway cross-section showing slowly adapting stretch receptors in smooth muscle with vagal afferents to brainstem inhibiting inspiration via Hering-Breuer reflex. Panel B: Rapidly adapting irritant receptors in airway epithelium connecting to cough and bronchoconstriction responses. Panel C: J receptors in alveolar walls adjacent to capillaries activated by edema producing rapid shallow breathing. Panel D: Muscle spindles in intercostal muscles providing load compensation feedback with clinical correlations for pulmonary edema and overinflation prevention.
---
### VII. Higher Brain Influences
While the brainstem generates the basic respiratory rhythm, higher brain centers modify breathing for behavioral and emotional needs. Understanding these influences explains both normal variations in breathing pattern and certain pathological respiratory conditions.
The cerebral cortex provides voluntary control over breathing, enabling breath-holding, speaking, singing, and playing wind instruments. Corticospinal pathways bypass the automatic brainstem pattern generators to directly activate respiratory muscles. This voluntary control demonstrates remarkable flexibility: breath-holding for several minutes with training, precise respiratory adjustments for speech, and complex coordination during athletic activities.
Limits exist to voluntary respiratory control. Breath-holding eventually terminates when rising carbon dioxide and falling oxygen stimulate chemoreceptors beyond the threshold that can be voluntarily suppressed. The breaking point typically occurs at arterial carbon dioxide tensions around 50 mmHg. Hyperventilation before breath-holding can extend duration by lowering initial carbon dioxide tension, but carries the risk of hypoxic syncope if oxygen falls to dangerous levels before carbon dioxide rises enough to force breathing.
The limbic system imposes emotional influences on breathing. Fear and anxiety typically produce hyperventilation. Grief may cause sighing respirations. Pain and stress alter breathing pattern. These effects, mediated through connections from limbic structures to brainstem respiratory centers, explain the respiratory symptoms accompanying emotional states.
The hypothalamus influences breathing through temperature regulation. Hyperthermia increases ventilation (thermal polypnea), helping dissipate heat. Hypothermia reduces ventilation.
Sleep profoundly affects respiratory control. During non-rapid eye movement sleep, ventilation decreases, the carbon dioxide response diminishes, and the apneic threshold rises, making breathing more vulnerable to instability. During rapid eye movement sleep, breathing becomes irregular as skeletal muscle atonia affects accessory respiratory muscles, leaving the diaphragm as the primary respiratory muscle. These sleep-related changes predispose to sleep-disordered breathing.
Panel A: Sagittal brain section with cortex arrows for voluntary control including breath-holding and speech converging on brainstem respiratory centers. Panel B: Limbic system arrows showing emotional influences from anxiety and fear plus hypothalamus arrows for temperature regulation. Panel C: Graph of breath-holding duration versus arterial PCO2 demonstrating breaking point when chemoreceptor stimulation overcomes voluntary suppression. Panel D: Sleep panel with EEG patterns during wakefulness, NREM, and REM showing decreased ventilation in NREM, irregular breathing in REM, and accessory muscle atonia.
---
### VIII. Integrated Responses
The respiratory control system integrates multiple inputs to produce appropriate responses to complex physiological challenges. Exercise and altitude adaptation represent two important examples of integrated ventilatory responses.
The ventilatory response to exercise occurs in three phases. Phase 1 begins immediately at exercise onset, before any change in blood gases could occur. Ventilation increases abruptly through neural mechanisms: anticipatory signals from the cortex, proprioceptive input from moving limbs, and possibly conditioned responses. This neural drive ensures that ventilation begins increasing simultaneously with metabolic demand.
Phase 2 involves a more gradual exponential rise in ventilation over the first few minutes of exercise. During this phase, chemical and metabolic factors contribute, including rising carbon dioxide production, increased blood potassium from exercising muscle, slight increases in arterial carbon dioxide oscillations, and metabolic acidosis at higher intensities. Muscle afferents detecting metabolite accumulation may provide additional input.
Phase 3 represents the steady state, where ventilation plateaus at a level proportional to metabolic rate. Remarkably, arterial blood gases typically remain normal during moderate exercise, demonstrating the precision of ventilatory matching to metabolism. This phenomenon, termed exercise hyperpnea, achieves large increases in ventilation without the blood gas changes that drive resting ventilatory responses. Only at high exercise intensities does metabolic acidosis from lactate production drive additional hyperventilation.
Altitude acclimatization presents a different challenge. Upon acute exposure to high altitude, the reduced inspired oxygen partial pressure produces hypoxemia. Peripheral chemoreceptors detect this and stimulate hyperventilation. However, the resulting hypocapnia produces respiratory alkalosis that inhibits both central and peripheral chemoreceptors, limiting the ventilatory response.
Over hours to days, renal compensation for respiratory alkalosis increases bicarbonate excretion, lowering serum bicarbonate and normalizing pH. With normal pH, the inhibition of chemoreceptors resolves, allowing further increases in ventilation. This process of ventilatory acclimatization continues for weeks, with progressive increases in ventilation and decreases in arterial carbon dioxide tension. Long-term altitude residents also develop increased sensitivity of the hypoxic ventilatory response.
Panel A: Exercise ventilation graph showing Phase 1 abrupt neural onset, Phase 2 gradual mixed neural-chemical rise, and Phase 3 steady state matched to metabolism. Panel B: Exercise annotations noting arterial blood gases remain normal despite large ventilation increases with neural and chemical contributions labeled. Panel C: Altitude acclimatization showing initial hypoxic hyperventilation causing hypocapnia and alkalosis limiting further response. Panel D: Timeline of altitude adaptation over days to weeks with renal compensation normalizing pH and sequential changes in ventilation, PCO2, pH, and bicarbonate.
---
### IX. Abnormal Breathing Patterns
Disease processes affecting the respiratory control system produce characteristic abnormal breathing patterns. Recognition of these patterns provides diagnostic information and guides treatment decisions.
Cheyne-Stokes respiration exhibits a regular waxing and waning pattern with periods of apnea. Ventilation gradually increases from apnea to hyperpnea over 30 to 60 seconds, then gradually decreases back to apnea, repeating cyclically. This pattern results from instability in the respiratory control feedback loop, typically due to prolonged circulation time in heart failure or increased controller gain in some central nervous system disorders. The prolonged circulation time means that blood gas changes from altered ventilation take longer to reach chemoreceptors, creating phase delay that produces oscillation rather than stable control.
Biot's respiration, also called ataxic breathing, produces irregular breathing with unpredictable apneas. Unlike the regular periodicity of Cheyne-Stokes, Biot's breathing shows chaotic rhythm generation, typically from damage to the medullary respiratory centers. This pattern often indicates serious brainstem injury with poor prognosis.
Kussmaul breathing produces deep, rapid respirations without pauses. This pattern represents maximal respiratory compensation for severe metabolic acidosis, characteristically seen in diabetic ketoacidosis. The deep breaths maximize carbon dioxide elimination to partially correct the acidemia.
Apneustic breathing features prolonged inspiratory gasps with brief expiratory phases. This pattern results from loss of the pneumotaxic center's inspiratory-limiting function, typically from pontine lesions. The apneustic center drives prolonged inspiration without the normal off-switch mechanism.
Sleep apnea represents intermittent respiratory arrest during sleep. Obstructive sleep apnea occurs when pharyngeal muscle relaxation during sleep allows upper airway collapse, despite continuing respiratory effort. Loud snoring, witnessed apneas, and daytime somnolence characterize this common condition. Central sleep apnea results from periodic loss of ventilatory drive during sleep, producing apnea without respiratory effort. Mixed patterns combining both mechanisms are common.
Panel A: Cheyne-Stokes respiration tracing showing crescendo-decrescendo pattern with regular apneic periods and feedback loop delay mechanism annotation. Panel B: Biot's breathing tracing showing irregular chaotic respirations with random apneas indicating medullary damage. Panel C: Kussmaul breathing tracing showing deep rapid respirations without pauses linked to metabolic acidosis and apneustic breathing with prolonged inspiratory plateaus. Panel D: Sleep apnea comparison with obstructive showing continued effort during absent airflow versus central with both effort and airflow absent on simultaneous tracings.
---
### X. Clinical Applications
Understanding respiratory control enables rational management of several clinical conditions involving abnormal ventilatory responses.
Supplemental oxygen therapy in patients with chronic obstructive pulmonary disease and carbon dioxide retention requires careful titration. These patients have developed blunted sensitivity to elevated carbon dioxide due to chronic hypercapnia and compensatory normalization of cerebrospinal fluid pH. Their ventilatory drive may depend significantly on hypoxic stimulation from peripheral chemoreceptors. Administering high-concentration oxygen can remove this hypoxic drive, further reducing ventilation and worsening carbon dioxide retention. The recommended approach targets oxygen saturation of 88 to 92 percent, providing adequate oxygenation while maintaining some hypoxic ventilatory stimulus.
Central hypoventilation syndromes result from inadequate chemoreceptor sensitivity or central integration of respiratory drive. Congenital central hypoventilation syndrome, also called Ondine's curse, results from PHOX2B gene mutations affecting autonomic development, including brainstem chemoreceptor function. These patients lack normal ventilatory responses to hypercapnia and hypoxemia, requiring mechanical ventilation especially during sleep when the wakefulness drive to breathe disappears. Obesity hypoventilation syndrome combines reduced chemosensitivity with mechanical restriction from obesity, producing chronic hypercapnia. Drug-induced central hypoventilation occurs with opioids, sedatives, and anesthetics that suppress brainstem respiratory centers.
Hyperventilation syndrome typically occurs in the context of anxiety, producing symptoms from hypocapnia and respiratory alkalosis. Rapid, deep breathing lowers arterial carbon dioxide, causing cerebral vasoconstriction (lightheadedness, visual changes) and increased neuromuscular excitability (perioral and extremity paresthesias, carpopedal spasm). Blood gas analysis confirms respiratory alkalosis. Management involves reassurance, treatment of underlying anxiety, and techniques to slow breathing.
High altitude illness encompasses a spectrum of disorders resulting from hypoxemia at elevation. Acute mountain sickness produces headache, nausea, fatigue, and sleep disturbance within hours of ascent. High altitude cerebral edema represents severe progression with ataxia and altered mental status. High altitude pulmonary edema causes dyspnea, cough, and hypoxemia from non-cardiogenic pulmonary edema. Prevention involves gradual ascent and prophylactic acetazolamide, which induces metabolic acidosis to enhance ventilatory acclimatization.
Panel A: COPD oxygen therapy flow diagram showing high FiO2 removing hypoxic drive leading to hypoventilation and worsened hypercapnia with recommended SpO2 target 88-92%. Panel B: Central hypoventilation syndromes including congenital PHOX2B mutation, obesity hypoventilation with elevated PCO2, and drug-induced opioid types with management approaches. Panel C: Hyperventilation syndrome showing anxiety-hyperventilation-symptoms cycle with typical ABG findings of respiratory alkalosis and treatment approach. Panel D: High altitude illness spectrum from AMS to HACE to HAPE with prevention strategies including gradual ascent and acetazolamide prophylaxis.
---
## Summary
Respiratory control originates in brainstem centers, with the medulla generating the basic rhythm and pontine centers modulating pattern. The pre-Bötzinger complex serves as the primary pacemaker for inspiration. The characteristic inspiratory ramp signal gradually increases activity before abrupt termination initiates passive expiration.
Central chemoreceptors on the ventral medullary surface respond to hydrogen ions in cerebrospinal fluid, primarily derived from carbon dioxide. These receptors provide approximately 80 percent of the ventilatory response to elevated carbon dioxide. Peripheral chemoreceptors in carotid and aortic bodies detect low oxygen partial pressure, elevated carbon dioxide, and low pH. The oxygen response activates primarily below arterial oxygen partial pressure of 60 mmHg.
The carbon dioxide response follows a linear curve with a slope of 2-3 liters per minute per mmHg. Chronic hypercapnia blunts this response through compensatory normalization of cerebrospinal fluid pH, increasing reliance on hypoxic drive. The oxygen response follows a hyperbolic curve with threshold at approximately 60 mmHg. These responses interact synergistically, with hypoxemia enhancing carbon dioxide sensitivity and vice versa.
Mechanoreceptors including pulmonary stretch receptors mediate the Hering-Breuer reflex, limiting inspiration during lung inflation. Irritant receptors trigger cough and bronchoconstriction. J receptors respond to interstitial edema with rapid shallow breathing.
Exercise hyperpnea matches ventilation to metabolism through neural and chemical mechanisms while maintaining normal arterial blood gases. Altitude acclimatization involves initial hypoxic hyperventilation limited by alkalosis, followed by renal compensation allowing further ventilatory increase.
Abnormal patterns including Cheyne-Stokes, Biot's, Kussmaul, and apneustic breathing indicate specific pathophysiological processes. Clinical applications include careful oxygen titration in chronic hypercapnia, recognition of central hypoventilation syndromes, management of hyperventilation syndrome, and prevention of high altitude illness.
---
## Key Terms
| Term | Definition |
|------|------------|
| Pre-Bötzinger complex | Pacemaker neurons generating respiratory rhythm |
| Central chemoreceptor | Medullary receptor responding to CSF H⁺ |
| Peripheral chemoreceptor | Carotid/aortic body detecting PO₂, PCO₂, pH |
| Hering-Breuer reflex | Lung inflation inhibiting inspiration |
| Cheyne-Stokes | Crescendo-decrescendo breathing with apnea |
| Hypoxic ventilatory response | Increased ventilation from low PaO₂ |
---
*This content is subject to the [MIT License](https://opensource.org/licenses/MIT). © 2024–2026 Hibbert School of Medicine.*